Michael Ackermann, Director at Tarsus Pharmaceuticals, Inc. (TARS), sold 1,283 shares at $25.00 ($32K) on 2021-08-05, disclosed to the SEC on 2021-08-06.
Scheduled sale ($32k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.00 | 1,183 | $30K | 92.2% |
| 2 | $25.01 | 100 | $3K | 7.8% |
| Total | $25.00 avg | 1,283 | $32K | 100% |
| Filing → |
| TARS | SELL | 2021-11-03 | $300K | — | Filing → |
| TARS | SELL | 2021-10-14 | $267K | — | Filing → |
| TARS | SELL | 2021-10-12 | $5K | — | Filing → |